Arlington Office Patients: We apologize for any inconvenience. Currently our phones are down at our Arlington office. We hope for resolution soon. If you need to reach the Arlington office, please call our main number at 571.350.8400. Thank you for your patience. Note: If you’re a federal employee and have questions about continuing coverage, please speak to your Patient Benefits Specialist and visit our insurance page here: .
An orally available inhibitor of extracellular signal-regulated kinase (ERK), with potential antineoplastic activity. Upon oral administration, LTT462 binds to and inhibits ERK, thereby preventing the activation of ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is upregulated in numerous tumor cell types and plays a key role in tumor cell proliferation, differentiation and survival. Check for active clinical trials using this agent.
Related Posts
Recent Posts
